iFD-SuRvivE funCtiONal effiCacy and bIologicaL corrElates (RECONCILE Study)
RECONCILE
The SURVIVE 2 Project: An Extended Cohort Study to Investigate Suicidal Behavior in Spain and the Efficacy of Secondary Prevention Strategies: iFD-SuRvivE funCtiONal effiCacy and bIologicaL corrElates (RECONCILE Study)
1 other identifier
interventional
120
1 country
4
Brief Summary
The goal of this clinical trial is to assess the effectiveness of an original intervention 'Functional Recovery in Depression and Suicide Risk Prevention Based on Emotion Regulation and Values: A Group Program' (from the original Spanish version: Programa Grupal De Recuperación Funcional En Depresión Y Prevención De Riesgo Suicida Basado En Regulación Emocional Y Valores) in depressed patients who have recently attempted suicide by improving their psychosocial functioning and therefore enhancing their ability to perform activities of daily living. As secondary objectives, the effectiveness of the intervention will be evaluated by determining cognitive performance (particularly decision-making, inhibition, and attention), quality of life, clinical status, and their relationship with neuroimaging correlates. Main target neuroimaging areas include the orbitofrontal cortex and dorsal prefrontal cortex.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2022
CompletedFirst Posted
Study publicly available on registry
December 19, 2022
CompletedStudy Start
First participant enrolled
September 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
May 12, 2026
May 1, 2026
1.5 years
October 25, 2022
May 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychosocial functioning changes in Functioning Assessment Short Test (FAST).
SA+Dep receiving the RECONCILE Intervention will show a decrease in FAST scores, compared to those SA+Dep receiving TAU. Lower general scores on this scale indicate better psychosocial functioning.
Baseline; 3 months after intervention (short assessment form); 12 months after intervention (full assessment)
Secondary Outcomes (8)
Cognitive changes in executive functions, specifically in decision-making measured by the modified version of the Iowa Gambling Task (IGT) with functional Magnetic Resonance (fMRI).
Baseline; 12 months after intervention
Cognitive changes in executive functions, specifically in impulsivity measured by Stroop Test (Stroop).
Baseline, 3 months after intervention (short assessment form); 12 months after intervention (full assessment).
Cognitive changes in executive functions, specifically in attention measured by Conners' Performance Test (CPT-III).
Baseline; 3 months after intervention (short assessment form); 12 months after intervention (full assessment).
Changes in self-reported quality of life by Quality of Life 5-Dimensions scale (EuroQoL-5D).
Baseline, 3 months after intervention (short assessment form); 12 months after intervention (full assessment).
Clinical changes in suicidal behavior assessed by the Columbia-Suicide Severity Rating Scale (C-SSRS).
Baseline; 3 months after intervention (short assessment form); 12 months after intervention (full assessment).
- +3 more secondary outcomes
Study Arms (2)
Treatment As Usual
NO INTERVENTION(TAU)
Intervention Group
EXPERIMENTALTreatment As Usual + RECONCILE Psychological Intervention.
Interventions
The RECONCILE psychological intervention, a structured telematic group program integrating components mainly from ACT, but also CBT, DBT, psychoeducation, and the collaborative construction of the Safety Planning Intervention (SPI). The aim of this therapy is to help individuals acquire strategies to regulate emotions, improve decision-making and daily functioning, and reduce the risk of suicidal behavior. The SPI will be conducted by identifying warning signs and providing each individual with personalized coping strategies and sources of support. Main skills to be acquired and integrated for the individual are: 1) SPI by six steps (identification of warning signs; applying internal coping strategies; use of social contacts as distraction; contacting family or significant others; contacting professionals and emergency services; making the environment safer), 2) Mindfulness, 3) Distress tolerance, 4) Emotional regulation, and 5) Values-based decision-making and behavioral activation.
Eligibility Criteria
You may qualify if:
- Age over 18 years old
- Having attempted suicide
- Provide written informed consent
- No claustrophobia/metallic objects/implants
You may not qualify if:
- Intelligence quotient below 70 and impaired functioning
- Any medical condition that could affect neuropsychological performance (such as neurological diseases) or a history of head trauma with loss of consciousness
- Participation in any structured psychological intervention within the past 6 months
- Patients who received electroconvulsive therapy within the past 6 months
- Inability to give inform consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Iria Grandelead
Study Sites (4)
Hospital Clínic Barcelona
Barcelona, Barcelona, 08036, Spain
Hospital del Mar
Barcelona, Spain
Hospital Clínico San Carlos
Madrid, Spain
Hospital Gregorio Marañón
Madrid, Spain
Related Publications (1)
Roberto N, Vazquez M, Radua J, Pariente JC, Munoz-Moreno E, Laredo C, Bracco L, Fernandez T, Martin-Parra S, Martinez-Aran A, Sanchez-Moreno J, Saiz P, Ruiz-Veguilla M, Borras R, Toll A, Elices M, Brambilla P, Courtet P, Perez-Sola V, Vieta E, Grande I. Safety intervention for improving functioning in suicidal attempters (STRONG): A secondary prevention study. Study rationale and research protocol. Span J Psychiatry Ment Health. 2026 Jan-Mar;19(1):66-72. doi: 10.1016/j.sjpmh.2023.05.001. Epub 2023 Aug 25.
PMID: 38591829DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Iria Grande
IDIBAPS- Hospital Clinic de Barcelona
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
October 25, 2022
First Posted
December 19, 2022
Study Start
September 16, 2025
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
May 12, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- When approved by the PI. For a period of 6 months at maximum.
- Access Criteria
- Only coded data will be transferred to third parties and to other countries, which in no case will contain information that can directly identify the participant (such as name and surname, initials, address, social security number, etc.). In the event of such a transfer, it would be for the same purpose of the study described above and guaranteeing confidentiality.
Data will be shared only under a justified request. Names and personal data will never be displayed or shared with third parties. The data will be collected in an information file owned by the center. The research team undertakes to preserve the privacy of patients and the confidentiality of data, in accordance with the Organic Law 3/2018, 5th December, about Personal Data Protection. In case of transfer of data to third parties (external promoter to the center) these will be transferred in an encrypted system, eliminating any data that could identify the patient. Only the principal investigator and her team will have access to the list of patient identification codes.